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Abstract 
BACKGROUND: Various techniques have been implemented to reconstruct the deficient interdental papilla. 
AIM: The present trial was conducted to assess the effect of injection of hyaluronic acid gel for the reconstruction 
of deficient interdental papilla. 
MATERIAL AND METHODS: Thirty-six deficient interdental papilla sites in ten patients were randomly allocated 
into two equal groups; intervention group who received the injection of hyaluronic acid (HA) gel and control group 
who received the injection of saline solution as a placebo. Each deficient papilla received three injections. The first 
injection was given one week following the re-evaluation period (four weeks after performing full mouth supra-
gingival scaling and sub-gingival debridement). The second and third injections were given after three and six 
weeks, respectively. The height and surface area of black triangles were recorded at baseline before the injection 
procedures. The participants were recalled after three and six months from the first injection for re-measuring the 
recorded parameters. At 6 months, patients' satisfaction was also assessed. 
RESULTS: After three and six months from baseline, the results revealed a statistically significant higher mean 
decrease in height and surface area of black triangles in favour of the HA group. From three to six months, there 
was no statistically significant difference between the two groups in both parameters. At 6 months, the HA group 
showed a statistically significant higher mean satisfaction score than the saline group. 
CONCLUSION: The use of hyaluronic acid gel for the reconstruction of interdental papillary deficiency was 
effective with promising levels of patients' satisfaction. 
 
 
 
Introduction 
 
The interdental papilla is the gingival portion 
that occupies the proximal area underneath the 
contact between two adjacent teeth. It has distinctive 
anatomical, histological and molecular characteristics 
with tremendous significant importance from an 
esthetic perspective, especially in the anterior region 
since it is almost universally displayed during smiling 
[1]. 
The interdental papillary deficiency or "the 
black triangle (BT)" is a large concern for dentists and 
patients [2]. Black triangles are rated as the third most 
disliked esthetic problem below caries and apparent 
crown margins [3]. Also, the absence of interdental 
papilla contributes to chronic retention of food debris 
leading to subsequent affection of periodontal health. 
Last but not least, it also causes phonetic problems by 
allowing the passage of air and saliva [4]. 
Reconstruction of papillary insufficiency is one of the 
most difficult and challenging periodontal treatments. 
This is because the interdental papilla is a small, 
fragile area with minor blood supply which seems to 
be the major limiting factor in all surgical and 
augmentation techniques aiming at reconstructing the 
interdental papilla [5], [6]. 
Several surgical approaches using traditional 
periodontal plastic and augmentation procedures have 
been proposed to overcome this problem. However, 
these techniques were found to be invasive with 
increased patient morbidity, limited success and long-
term stability [7], [8]. Non-surgical attempts to treat 
papillary deficiencies include orthodontic, restorative 
approaches or a combination of both. However, these 
methods are invasive, but time-consuming [4]. 
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Hyaluronic acid (HA) is an essential 
glycosaminoglycan of the extracellular matrix of the 
periodontal tissues, and the majority of cells can 
produce it during several phases of their cell cycle. It 
is involved in tissue repair and wound healing by 
stimulating cell proliferation, migration and interaction 
with several growth factors. Furthermore, HA has a 
crucial role in space-filling owing to its hygroscopic 
nature. Moreover, it regulates osmotic pressure and 
enhances tissue lubrication and resiliency, which 
helps in maintaining the structural and homeostatic 
integrity of tissues [9]. Limited studies have utilised 
HA gels for papillary reconstruction but still lacking a 
high degree of evidence and predictability [2], [4], [10], 
[11], [12]. More studies are needed to evaluate the 
use of injectable HA-based gels as a minimally 
invasive approach for the treatment of interdental 
papillary loss.  
Therefore, the aim of this randomised, 
placebo-controlled, parallel-grouped clinical trial was 
to assess the effect of injection of HA gel for the 
reconstruction of deficient interdental papilla. 
 
 
Material and Methods 
 
Patients' Selection 
This study was carried out according to the 
ethical guidelines of the World Medical Association; 
Declaration of Helsinki as revised in 2000 for studies 
involving human participants and the protocol was 
approved by the Medical Ethical Committee at the 
National Research Centre (NRC) with a code no. 16 7 
27. The procedures and follow up periods were clearly 
described in details to the selected patients. All 
included subjects signed written consent with the full 
agreement of participation in this study.  
Sample size calculation based on previously 
published work [10], [11], [12] showed the probability 
of improvements among the study group, which was 
0.97. Assuming that the true probability of 
improvements among the control group was 0.5, 13 
intervention sites and 13 control sites were needed to 
conduct the study to be able to reject the null 
hypothesis that the exposure rates for intervention 
and control are equal with the power of 0.8. This 
number was increased in each group for correct non-
parametric usage and to compensate for losses 
during the follow-up period. 
Ten patients (3 males and 7 females, aged 21 
to 47 years) with 36 papillae were selected from the 
outpatient clinic, Department of Oral Medicine and 
Periodontology, Faculty of Dentistry, Cairo University 
and outpatient clinic of Oral and Dental Research 
Division at NRC.  
The inclusion criteria involved highly 
motivated patients having at least one deficient papilla 
in the inter-bicuspid region. Papillary deficiency types I 
or II, according to Nordland and Tarnow classification 
[13] were selected. Distance between the contact 
point and inter-proximal bone crest (CP-BC) of ≤ 7 
mm and probing depth of ≤ 4 mm at the deficient 
papillary sites was mandatory for inclusion in the 
study. Also, full mouth plaque index (PI) and gingival 
index (GI) scores should be between 0-1. No open 
contacts between affected teeth should be present. 
Teeth free from caries, proximal restorations, fixed 
prosthesis or orthodontic appliances were selected.  
Exclusion criteria excluded subjects with 
medical conditions that may affect periodontal healing 
or regeneration. Subjects with a history of allergic 
reactions, pregnant or breastfeeding females, 
smokers and alcoholics were not included. Patients 
with current or previous drugs intake that may 
predispose to gingival enlargement were not allowed 
to participate. Patients under orthodontic treatment or 
had orthodontic treatment in the past six months were 
not selected. Patients with a history of traumatic oral 
hygiene measures or periodontal surgeries over the 
last six months at the area of interest were not 
endorsed. 
The participants were randomly assigned into 
two groups to receive either hyaluronic acid gel 
injection or saline injection as a placebo using a 
distance randomisation procedure with 1:1 allocation 
ratio. If the patient had more than one eligible deficient 
papilla, these papillae were allocated to the same 
treatment group. Allocation concealment was 
achieved by using sequentially numbered, opaque 
and sealed envelopes. This trial was double-blinded, 
where blinding included patients and the outcome 
assessor. It was impossible for the researcher to be 
blinded due to the difference in consistency and 
resistance to injection between hyaluronic acid gel 
and saline solution. 
Two patients with a total of 6 deficient papillae 
(2 in the intervention group and 4 in the control group) 
did not finish their series of injections and follow up 
periods, so they were considered dropouts. This made 
a total of 8 patients with 30 deficient papillae (16 in the 
intervention group and 14 in the control group) who 
had completed the injections and followed ups and 
their outcomes were subjected to statistical analysis. 
 
Hyaluronic Acid Gel  
The product used in this trial was Restylane 
Lidocaine (Restylane-Lidocaine cross-linked 
Hyaluronic Acid Filler, Galderma S.A, Sweden). 
Restylane was the first FDA-approved HA filler in 
2003. Restylane is a non-animal stabilised cross-
linked HA filler with an HA concentration of 20 mg/ml. 
The longevity of Restylane filler in tissues is 
approximately 6 months. Restylane-Lidocaine (FDA 
approved in 2012) is a newer product of Restylane 
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with 0.3% lidocaine incorporated into the syringe itself 
[14]. 
 
Treatment Protocol 
The treatment protocol was divided into 3 
phases: the pre-operative phase, where patients were 
examined for eligibility, the injection phase and the 
follow up phase. 
In the pre-operative phase, the 1
st
 visit started 
by collecting detailed personal information, medical 
and dental history. Initial periodontal therapy including 
full mouth supragingival scaling and subgingival 
debridement was performed, and patient motivation 
and education for proper oral hygiene instructions 
were reassured. The distance between the contact 
area and inter-proximal bone crest (CP-BC) was then 
measured for eligibility at the sites of papillary 
deficiency using peri-apical radiographs with the 
paralleling technique and confirmed by bone 
sounding. Only sites with CP-BC distance ≤ 7mm 
were eligible for the study 
After 4 weeks, re-evaluation was performed, 
and the degree of papillary deficiency according to 
Nordland and Tarnow classification [13] as well as 
plaque and gingival indices were assessed for 
eligibility. Alginate impression was taken for the 
involved arch/arches for the construction of study 
casts and fabrication of customised stents. Only 
patients with deficient papilla site/sites fulfilling the 
inclusion criteria were recalled, scheduled for the 1
st
 
injection after 1 week and signed the informed 
consent. 
In the injection phase, 3 injections were given 
at each papilla site: at baseline, 3- and 6-weeks 
intervals. At the first injection visit, before attempting 
to inject, clinical measurement of the height of the 
black triangle was done by measuring the distance 
between the deficient papilla tip and contact area (PT-
CP distance) to the nearest 0.5 mm (baseline). This 
was done using a graduated periodontal probe and 
the fabricated customised stent for proper and 
standardised positioning of the probe at each 
measurement interval, as shown in Figure 1.  
 
Figure 1: Measuring the height of the black triangle (PT-CP 
distance) 
 
Also, standardised digital clinical photographs 
were taken for the eligible deficient papillae for the 
baseline measurement of the surface area of black 
triangles. Then, the patient allocation was revealed, 
whether to the intervention group (HA group) or 
control group (saline group) and patients were ready 
to receive their first injection.  
Every injection procedure starts with the 
administration of short-acting local anaesthesia using 
infiltration technique. The deficient papilla was 
injected with 0.1 mm of HA gel or saline solution using 
a 30-gauge disposable insulin syringe. Hyaluronic 
acid and saline were pre-loaded in insulin plastic 
syringes before injection for patient blinding. The 
needle was inserted 2-3 mm apical to the tip of the 
interdental papilla and directed coronally with an 
angulation of 45° to the long axis of the tooth, and the 
bevel directed apically (Figure 2). Then, the papilla 
was lightly moulded in an incisal direction for 1 minute 
using gauze. Finally, post-injection instructions were 
prescribed where 24-hour abstinence from 
mechanical plaque control in the area and the use of 
mouthwash twice daily only was advocated. The use 
of a soft toothbrush, together with the use of 
mouthwash, was indicated after the first 24 hours. 
Routine mechanical oral hygiene was resumed after 2 
weeks. 
 
Figure 2: Injection technique 
 
In the follow-up phase, patients were recalled 
after 3 and 6 months from the first injection where 
clinical re-measurement of the black triangles and 
standardised digital clinical photographs were retaken. 
  
Calculation of the surface area of black 
 triangles 
The surface area of the black triangle (SABT) 
was assessed using standardised digital clinical 
photographs analysed by an image analysis program 
(Photoshop Cs 5, Adobe Systems, San Jose, CA, 
USA). The surface area of the black triangle was 
assessed from the photographs taken at baseline 
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(before injection), 3 and 6 months from the first 
injection.  
Clinical photographs were obtained with the 
same digital camera (Nikon D5100 DSLR) mounted 
on a ring flashlight, using the same lens (Sigma Macro 
105mm F2.8 EX) and the same focal length. The 
photographs were taken under the same lightning 
conditions and camera settings. The patients were 
sitting in an upright position, looking straight ahead. 
The Frankfort plane of the patient as well as the 
camera lens was positioned parallel to the ground. 
The photographs were captured perpendicular to the 
teeth adjacent to the deficient papilla. Strict care was 
taken to ensure that the same up-down and right-left 
shooting positions were reproduced at different time 
intervals.  
For analysis, the photographs were imported 
to Photoshop CS5. The contrast of each photograph 
was adjusted to ensure that the borders of the black 
triangle were distinct. This was achieved by turning 
the area of the black triangle into completely black 
while the rest of the image turned white. The physical 
size corresponding to a pixel is different on 
photographs taken at different times. To reduce errors 
based on magnification, a 10 mm William's graduated 
periodontal probe was used as a scale for calibration 
to calculate the pixels value to be converted into mm. 
Then the base and height of the black triangle were 
measured in mm. The surface area of the black 
triangle (in mm
2
) was calculated using the formula (0.5 
X height X base) [12]. 
 
Assessment of Patients' Satisfaction 
At the end of the 6 months follow up period, 
patients' satisfaction about their esthetic appearance 
was assessed using visual analogue scale (VAS) 
ranging from 0 to 100 (0= unsatisfied/ worst 
imaginable appearance, 100= very satisfied/best 
imaginable appearance) [15]. Clinical photographs 
taken before the injection procedures were shown to 
every patient to compare between the pre and post-
injection appearance. The patient then filled in a 
printed VAS for patient satisfaction assessment. 
 
Statistical analysis 
Numerical data were explored for normality by 
checking the distribution of data using tests of 
normality (Kolmogorov-Smirnov and Shapiro-Wilk 
tests). Age and distance between the contact point 
and bone crest (CP-BC) data showed normal 
(parametric) distribution while height (PT-CP distance) 
and surface area of black triangle and satisfaction 
scores data showed non-normal (non-parametric) 
distribution. Data were presented as mean ± standard 
deviation (SD) values. For parametric data, Student’s 
t-test was used to compare between mean age and 
CP-BC distance values in the two groups. For non-
parametric data; Mann-Whitney U test was used to 
compare between the two groups. Wilcoxon signed 
rank test, and Friedman’s test was used to study the 
changes by time within each group. Dunn’s test was 
used for pair-wise comparisons between the follow-up 
times when Friedman’s test was significant. 
Qualitative data were presented as 
percentages. Fisher's exact test was used for 
comparisons regarding qualitative data. The 
significance level was set at p ≤ 0.05. Statistical 
analysis was performed with IBM SPSS Statistics 
Version 20 for Windows, USA. 
 
 
Results  
 
The present study was conducted on 8 
patients; 4 patients (1 male and 4 females) with 16 
deficient papillae in the HA group and 4 patients (1 
male and 4 females) with 14 deficient papillae in the 
saline group. 
 
Demographic results 
The mean age of the patients was 32.55 ± 9.3 
years. There was no statistically significant difference 
between mean age values (p = 0.718) or gender 
distributions (p = 1.000) between both groups.  
 
The height of the black triangle results 
The measurements of the height of the black 
triangle reported that there was no statistically 
significant difference between the two groups either at 
baseline (p = 0.718), after 3 months (p = 0.640) or 6 
months (p = 0.355).  
In HA group; there was a statistically 
significant decrease in PT-CP distance measurements 
after 3 months (p ˂ 0.001). From 3 to 6 months, there 
was no statistically significant change in PT-CP 
distance measurements. However, the mean PT-CP 
distance measurements after 6 months showed a 
statistically significant lower value than baseline 
measurements. Meanwhile, in the saline group, there 
was no statistically significant change in PT-CP 
distance measurements along the study periods (p = 
0.223). Comparison between changes in PT-CP 
distance in the two groups showed that from baseline 
to 3 months; HA group showed a statistically 
significant higher mean decrease in PT-CP distance 
than the saline group (p = 0.025). From 3 to 6 months, 
there was no statistically significant difference 
between the two groups (p = 0.822). From baseline to 
6 months; HA group showed a statistically significant 
higher mean decrease in PT-CP distance than the 
saline group (p = 0.047). 
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The surface area of the black triangle 
 (SABT) results 
The measurements of the SABT presented 
that there was no statistically significant difference 
between the two groups either at baseline or after 3 
months. After 6 months, the HA group showed 
statistically significantly lower mean SABT 
measurements than the saline group. In HA group; 
there was a statistically significant decrease in SABT 
measurements after 3 months (p ˂ 0.001). From 3 to 6 
months, there was no statistically significant change in 
the measurements. However, the mean SABT 
measurements after 6 months showed a statistically 
significant lower value than baseline measurements. 
While in the saline group, there was no statistically 
significant change in the measurements (p = 0.811). 
From baseline to 3 months; HA group showed a 
statistically significant higher mean decrease in SABT 
measurements than the saline group. From 3 to 6 
months, there was no statistically significant difference 
between the two groups. From baseline to 6 months; 
HA group showed a statistically significant higher 
mean decrease in SABT measurements than the 
saline group. 
 
Figure 3: Hyaluronic acid group; A) BT at baseline; B) BT at 3 
months; C) BT at 6 months 
 
Comparison between percentages (%) of 
change in SABT in the two groups showed that from 
baseline to 3 months; HA group showed statistically 
significant higher mean % decrease in the area than 
in the saline group (p ˂ 0.001). From 3 to 6 months, 
there was no statistically significant difference 
between the two groups (p = 0.224). From baseline to 
6 months; HA group showed a statistically significant 
higher mean % decrease in SABT than saline group 
(p ˂ 0.001). 
Correlation between changes in PT-CP 
distance and the SABT values revealed that from 
baseline to 3 months; there was a statistically 
significant direct (positive) correlation between 
changes in PT-CP distance and changes in SABT (p ˂ 
0.001). A decrease in changes in PT-CP distance is 
associated with a decrease in SABT measurements 
and vice versa. From 3 to 6 months, there was no 
statistically significant correlation between the two 
variables (p = 0.07). From baseline to 6 months; there 
was a statistically significant direct (positive) 
correlation between changes in PT-CP distance and 
changes in SABT (p = 0.001). A decrease in changes 
in PT-CP distance is associated with a decrease in 
SABT and vice versa. Figures 3 and 4 illustrate 
standardised clinical photographs and photo analysis 
at baseline, 3 and 6 months of HA case and saline 
case, respectively. 
 
Figure 4: Saline group; A) BT at baseline; B) BT at 3 months; C) BT 
at 6 months 
 
The patients' satisfaction results 
Regarding patients' satisfaction about the 
esthetic appearance, results of the present study 
observed that the HA group showed statistically 
significant higher mean satisfaction score than the 
saline group after 6 months (p = 0.002). Results of the 
present study are illustrated in Table 1. 
Table 1: Change in height and percentage of change in surface 
area of black triangles over time and satisfaction score after 6 
months 
Change in 
height (PT-
CP) 
of BT 
Time HA group 
(n = 16) 
Saline group 
(n = 14) 
p-value 
Baseline - 3 months -0.31± 0.25 -0.07± 0.18 0.025* 
Mean ± SD 
3 months - 6 months -0.06 ± 0.17 0.04 ± 0.13 0.822 
Mean ± SD 
Baseline - 6 months -0.25 ± 0.26 -0.03 ± 0.13 0.047* 
Mean ± SD 
Percentage 
of change in 
surface area 
of BT 
Baseline - 3 months -36.5 ± 24.4 -0.9 ± 10.6 < 0.001* 
Mean ± SD 
3 months - 6 months -11.8 ± 30.3 0.9 ± 8.9 0.224 
Mean ± SD 
Baseline - 6 months -45.0 ± 28.5 -2.0 ± 11.4 < 0.001* 
Mean ± SD 
Satisfaction 
score 
6 months 45 ± 12.65 27.86 ± 12.51 0.002* 
Mean ± SD 
*Significant: Significance level was set at p ≤ 0.05. 
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Discussion 
 
This randomized clinical trial aimed to assess 
the effect of injection of HA gel compared to a saline 
solution as a placebo for the reconstruction of 
deficient interdental papilla. This was presented as the 
change in height (PT-CP distance) and percentage of 
change in surface area of a black triangle; both 
measured at baseline, 3- and 6-months intervals. 
Since patients' reported outcomes are of paramount 
importance these days, patients' satisfaction of their 
final esthetic appearance was also assessed after at 
the end of the study using a visual analogue scale 
(VAS). 
Changes in the height of black triangles (PT-
CP distance) over time in the present study were 
compared between the HA and saline groups. A 
statistically significant higher mean decrease in PT-
CP was observed in favour of the HA group at 
baseline, 3 and 6 months. These results are in 
contrast with the findings reported by Bertl et al., [2]. 
They reported no statistically significant difference 
between the two groups over time. Their results may 
be justified by the use of a gel with different HA 
concentration, different injection technique and the 
position of the papillary defects adjacent to implants. 
Such defects have different histological features 
compared to defects adjacent to natural teeth. 
The mean percentages of reduction in black 
triangle surface area in the HA group in the present 
study were 36.5 ± 24.4% and 45.0 ± 28.5% from 
baseline to 3 months and from baseline to 6 months 
respectively. These results are consistent with a 
previously conducted study [11] who reported mean 
percentages of reduction of 29.52 ± 18.72% in the 
period of baseline to 3 months and 47.33 ± 20.20% in 
the period of baseline to 6 months. In agreement with 
the present study, the mean percentage of reduction 
in another study performed by Awartani and Tatakis 
[12] was 41 ± 37% after 6 months. A case series [10] 
also reported a mean reduction percentage of 91.1 ± 
11.99% after 25 months to follow up following HA 
injection. They did not provide any data on SABT at 
baseline but only recommended the injection of HA 
gel on small papillary defects. The higher percentage 
of reduction in their study is most likely attributed to 
the smaller black triangles size at baseline, and the 
longer follows up period. Also, another case series [4] 
recorded a mean reduction percentage of 92.55% ± 
13.46% after 6 months. The mean surface area at 
baseline in their study was nearly 3 times smaller than 
the mean surface area at baseline in the present 
study. Moreover, the higher percentage of papillary fill 
in their study might be due to the use of a different HA 
gel with higher HA concentration and the higher 
number of injections. 
In the present study, results reported that HA 
group showed statistically significant higher mean 
satisfaction scores than the saline group. This goes in 
parallel with the statistically significant papillary fill 
observed in the HA group. These results are in 
agreement with a study conducted in 2015 [12] who 
evaluated the patients' satisfaction in which 7 out of 9 
patients were satisfied with their smile and the 
papillary fill, and 6 of them would choose to repeat the 
procedure. On the contrary, a previous study [2] found 
no statistically significant difference in VAS scores of 
patient's satisfaction after 6 months between the HA 
and saline groups at any time point or within the 
groups over time. This is consistent with the fact that 
no difference in papillary fill was found between the 
two groups. 
Although no complete papillary fill was seen in 
the HA group in the present study, the HA group 
showed higher satisfaction scores than the saline 
group. The satisfaction level of the aesthetic 
appearance is a subjective outcome seen in different 
perspectives. The use of HA-based gel caused a 
statistically significant increase in papillary fill; yet, 
incomplete papillary fill may somehow limit its clinical 
significance. The most critical pre-treatment 
determinant of complete papillary reconstruction is the 
size of the papillary defect before treatment. The 
choice of the eligible defects in the present study was 
dependent upon the distance between the CP-BC and 
the papillary classification according to Nordland and 
Tarnow [13]. This classification gives no highlights on 
the importance of the width and area of the black 
triangle at baseline. Complete papillary fill could be 
achieved in small papillary defects [10] and with 
increased number of injections [4]. 
In conclusion, within the limitations of this 
study, the use of commercially available hyaluronic 
acid gel for the treatment of interdental papillary 
deficiency was effective with promising levels of 
patients' satisfaction. This trial paves the way for a 
series of future studies to determine the appropriate 
protocol of injection and to identify the pre-treatment 
determinants for better outcomes. Further long-term 
studies should be conducted with larger sample size 
using higher HA concentrations with increasing the 
number of injections. 
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